Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to -$1.8 million.

  • Rockwell Medical's Net Income towards Common Stockholders fell 20901.44% to -$1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.7 million, marking a year-over-year decrease of 31210.37%. This contributed to the annual value of -$554000.0 for FY2024, which is 9367.58% up from last year.
  • Per Rockwell Medical's latest filing, its Net Income towards Common Stockholders stood at -$1.8 million for Q3 2025, which was down 20901.44% from -$1.6 million recorded in Q2 2025.
  • Rockwell Medical's Net Income towards Common Stockholders' 5-year high stood at $1.7 million during Q3 2024, with a 5-year trough of -$8.9 million in Q4 2021.
  • For the 5-year period, Rockwell Medical's Net Income towards Common Stockholders averaged around -$3.5 million, with its median value being -$2.1 million (2023).
  • As far as peak fluctuations go, Rockwell Medical's Net Income towards Common Stockholders soared by 17954.11% in 2024, and later plummeted by 63287.67% in 2025.
  • Over the past 5 years, Rockwell Medical's Net Income towards Common Stockholders (Quarter) stood at -$8.9 million in 2021, then soared by 73.59% to -$2.4 million in 2022, then skyrocketed by 31.71% to -$1.6 million in 2023, then surged by 51.7% to -$779000.0 in 2024, then plummeted by 132.86% to -$1.8 million in 2025.
  • Its Net Income towards Common Stockholders was -$1.8 million in Q3 2025, compared to -$1.6 million in Q2 2025 and -$1.6 million in Q1 2025.